NO921955L - Nye d-vitaminforbindelser og fremgangsmaate til fremstilling av samme - Google Patents

Nye d-vitaminforbindelser og fremgangsmaate til fremstilling av samme

Info

Publication number
NO921955L
NO921955L NO92921955A NO921955A NO921955L NO 921955 L NO921955 L NO 921955L NO 92921955 A NO92921955 A NO 92921955A NO 921955 A NO921955 A NO 921955A NO 921955 L NO921955 L NO 921955L
Authority
NO
Norway
Prior art keywords
hydroxyvitamin
dihydroxyvitamin
previously unknown
vitamin
compounds
Prior art date
Application number
NO92921955A
Other languages
English (en)
Norwegian (no)
Other versions
NO921955D0 (no
Inventor
Joyce C Knutson
Charles W Bishop
Original Assignee
Lunar Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lunar Corp filed Critical Lunar Corp
Publication of NO921955D0 publication Critical patent/NO921955D0/no
Publication of NO921955L publication Critical patent/NO921955L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5929,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/21Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a non-condensed ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
NO92921955A 1990-09-21 1992-05-18 Nye d-vitaminforbindelser og fremgangsmaate til fremstilling av samme NO921955L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58685490A 1990-09-21 1990-09-21
PCT/US1991/006865 WO1992005130A1 (en) 1990-09-21 1991-09-20 NOVEL 1α-HYDROXY VITAMIN D4 AND NOVEL INTERMEDIATES AND ANALOGUES

Publications (2)

Publication Number Publication Date
NO921955D0 NO921955D0 (no) 1992-05-18
NO921955L true NO921955L (no) 1992-06-05

Family

ID=24347363

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921955A NO921955L (no) 1990-09-21 1992-05-18 Nye d-vitaminforbindelser og fremgangsmaate til fremstilling av samme

Country Status (18)

Country Link
US (1) US5488120A (es)
EP (1) EP0503035B1 (es)
KR (1) KR100231809B1 (es)
CN (3) CN1032255C (es)
AR (1) AR247817A1 (es)
AU (1) AU650286B2 (es)
BR (1) BR9106062A (es)
CA (1) CA2069084C (es)
DE (1) DE69132862T2 (es)
DK (1) DK0503035T3 (es)
ES (1) ES2169023T3 (es)
HU (2) HU213471B (es)
MX (1) MX9101224A (es)
NO (1) NO921955L (es)
NZ (1) NZ239897A (es)
PL (1) PL170447B1 (es)
WO (1) WO1992005130A1 (es)
ZA (1) ZA917553B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5798345A (en) * 1990-09-21 1998-08-25 Bone Care International, Inc. Method of inhibiting the hyperproliferation of malignant cells
US5756783A (en) * 1990-09-21 1998-05-26 Bone Care International, Inc. 1α-Hydroxy-24-EPI-vitamin D4
US5763428A (en) * 1990-09-21 1998-06-09 Bone Care International, Inc. Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
CA2129120A1 (en) * 1992-01-29 1993-08-05 Joyce C. Knutson 1.alpha.-hydroxy-24-epi-vitamin d4
EP0562497A1 (en) * 1992-03-27 1993-09-29 Nisshin Flour Milling Co., Ltd. 1 alpha-hydroxy vitamins D7 and D4' processes for the preparation thereof and pharmaceutical compositions
NZ254424A (en) * 1992-06-22 1997-09-22 Lunar Corp Pharmaceutical composition and use of 1 alpha hydroxy-pre-vitamin d
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US6376479B1 (en) 1995-04-03 2002-04-23 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US20020183288A1 (en) * 1995-04-03 2002-12-05 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
KR20000071039A (ko) 1997-02-13 2000-11-25 비숍 찰스 더블유. 비타민 d 화합물의 표적화된 치료학적 전달
US6900191B1 (en) 1997-02-25 2005-05-31 Oncquest, Inc. 1α-Hydroxyvitamin D5, its synthesis and use in cancer prevention
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
AU762481C (en) * 1998-03-27 2004-08-19 Oregon Health Sciences University Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
EP1301479A2 (en) * 2000-07-18 2003-04-16 Bone Care International, Inc. STABILIZED 1$g(a)-HYDROXY VITAMIN D
JP2005504279A (ja) * 2001-09-27 2005-02-10 ザ・コカ−コーラ・カンパニー 食品のビタミン強化
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20050239756A1 (en) * 2004-04-23 2005-10-27 Bone Care International, Inc. Methods of treating various vitamin D metabolism conditions with 1alpha-hydroxyvitamin D2
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
CN108047108B (zh) * 2017-12-30 2019-09-20 南京海融制药有限公司 一种阿法骨化醇的有关杂质pzb及其制备方法和用途
CN108663442B (zh) * 2017-12-30 2021-03-30 南京海融制药有限公司 一种阿法骨化醇片剂有关物质的检查方法
CN108218750B (zh) * 2017-12-30 2019-09-10 南京海融制药有限公司 一种阿法骨化醇的异构体杂质的定向合成方法及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2383446A (en) * 1941-06-04 1945-08-28 Du Pont Antirachitic materials and processes for their production
DK138672B (da) * 1976-09-28 1978-10-16 Danske Sukkerfab Krystallisationsapparat.
US4202829A (en) * 1978-01-05 1980-05-13 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
NL188286C (nl) * 1978-01-16 1992-05-18 Wisconsin Alumni Res Found Werkwijze voor het bereiden van een 1alfa-hydroxyvitamine d verbinding.
US4260549A (en) * 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4195027A (en) * 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4362710A (en) * 1980-07-04 1982-12-07 Nissan Gosei Kogyo Co., Ltd. Feeds for baby pigs, process for preparing the same and method of breeding baby pigs
US4661294A (en) * 1985-03-18 1987-04-28 The General Hospital Corporation Biologically active 1-thio derivatives of vitamin D
DE3666587D1 (en) * 1985-08-02 1989-11-30 Leo Pharm Prod Ltd Novel vitamin d analogues
JP2550391B2 (ja) * 1988-06-30 1996-11-06 日清製粉株式会社 1β−ヒドロキシビタミンD▲下2▼およびD▲下3▼の製造方法
CA1333616C (en) * 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
JP2645130B2 (ja) * 1989-03-31 1997-08-25 日清製粉株式会社 ステロイド誘導体

Also Published As

Publication number Publication date
ES2169023T3 (es) 2002-07-01
CN1130507A (zh) 1996-09-11
KR920703487A (ko) 1992-12-18
HUT62559A (en) 1993-05-28
CN1136433A (zh) 1996-11-27
KR100231809B1 (ko) 1999-12-01
PL294706A1 (en) 1993-10-04
BR9106062A (pt) 1993-03-09
AU8542291A (en) 1992-04-15
NZ239897A (en) 1996-03-26
EP0503035B1 (en) 2001-12-12
ZA917553B (en) 1992-07-29
DK0503035T3 (da) 2002-04-15
CA2069084C (en) 2007-05-22
EP0503035A4 (es) 1994-03-30
HU211963A9 (en) 1996-01-29
WO1992005130A1 (en) 1992-04-02
DE69132862D1 (de) 2002-01-24
DE69132862T2 (de) 2002-08-29
PL170447B1 (en) 1996-12-31
CN1061220A (zh) 1992-05-20
HU9201691D0 (en) 1992-09-28
MX9101224A (es) 1992-05-04
NO921955D0 (no) 1992-05-18
HU213471B (en) 1997-06-30
AR247817A1 (es) 1995-04-28
CA2069084A1 (en) 1992-03-22
CN1032255C (zh) 1996-07-10
US5488120A (en) 1996-01-30
AU650286B2 (en) 1994-06-16
EP0503035A1 (en) 1992-09-16

Similar Documents

Publication Publication Date Title
NO921955L (no) Nye d-vitaminforbindelser og fremgangsmaate til fremstilling av samme
Baxter et al. Stimulation of 25-hydroxyvitamin D3-1alpha-hydroxylase by phosphate depletion.
Kragballe Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903)
Haussler et al. Biological activity of 1α-hydroxycholecalciferol, a synthetic analog of the hormonal form of vitamin D3
Raisz et al. Effect of osteoclast activating factor from human leukocytes on bone metabolism.
EP0914825A3 (en) Methods for preparation of 1 alpha, 24-dihydroxy vitamin D2
ES2309069T3 (es) Compuestos de 2-etil y 2-etiliden-19-nor-vitamina d.
AU5561686A (en) Method of increasing bone mass
Okamoto et al. Biological activity of 24, 24-difluoro-1, 25-dihydroxyvitamin D3
EP0474517B1 (en) Novel use of 1alpha-hydroxylated-19-nor-vitamin D compounds to treat psoriasis
GR3030939T3 (en) 1-g(a),24(S)-DIHYDROXY VITAMIN D 2?, ITS FORMATION AND USE.
KR19990022320A (ko) 암을 치료하기 위한 비타민 d₄유도체의 용도
KR102026800B1 (ko) 티오레독신을 함유하는 피부 외용제 조성물
JPH02288873A (ja) シクロビタミンd化合物
IE49753B1 (en) 24,24-difluoro-cyclovitamin d3 derivatives
CZ219798A3 (cs) Prostředek pro prevenci a léčbu osteoporézy
US4307231A (en) Vitamin D-lactone derivative and process for preparing same
DeLUCA Recent advances in our understanding of the metabolism of vitamin D and its regulation
DeLuca Regulation of vitamin D metabolism
ES2006121A6 (es) Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas.
Lawson et al. Biological activity of 10-hydroxy-vitamin D3 implications for the steric structure of the active form of vitamin D
ES2093226T3 (es) Retinoides sustituidos con un ciclo ditiano y su empleo, procedimiento de preparacion de dichos compuestos, composiciones cosmetica y farmaceutica que los contienen y empleo terapeutico de esta ultima.
Murayama et al. Synthesis and immunoregulating activity of vitamin D analogues bearing pregnane side chains
JP2000026235A (ja) 美白に好適な皮膚外用剤
JARNAGIN THE ACTIONS AND METABOLISM OF 24, 25 DIHYDROXYVITAMIN D (, 3) IN THE RAT (VITAMIN D, METABOLISM)